Description

CJC-1295 / Ipamorelin (No DAC) – Research Peptide Blend

CJC-1295 / Ipamorelin (No DAC) is a dual-peptide research formulation designed for laboratory studies of growth hormone (GH) signaling and pituitary-related endocrine pathways. This blend combines CJC-1295 (without DAC), a GHRH analog, with Ipamorelin, a selective GHS receptor agonist, to support controlled evaluation of peptide-driven endocrine mechanisms.

In research environments, this combination enables investigation of synergistic GH signaling while allowing precise study of receptor interactions and short-acting peptide dynamics. The No DAC variant is ideal for laboratory models requiring temporal control of GH-related pathways.

Available Research Quantity

• 10mg total (5mg CJC-1295 / 5mg Ipamorelin)

Research Applications

Researchers commonly study this blend for:

• Investigating growth hormone secretion pathways

• Examining GHRH and GHSR-1a receptor interactions

• Exploring IGF-1–related signaling models

• Studying metabolic and anabolic molecular pathways

• Evaluating multi-peptide synergy in pituitary signaling

Quality & Verification

Each peptide is manufactured to ≥99% purity and undergoes verification using HPLC and mass spectrometry to ensure consistency, stability, and analytical accuracy for controlled laboratory research applications.

Research Use Disclaimer

This product is intended strictly for laboratory research use only.
Not for human or veterinary consumption.
Handling is restricted to qualified professionals operating in approved research environments.